Cognition Therapeutics (CGTX) Live Share Price, Invest From India

Cognition Therapeutics Stock Performance

as on September 5, 2026 at 6:59 am IST

Day's Low
Day's High
$1.01
Day's Price Range
$1.04
$1.03
1.94%
Downside
0.97%
Upside
52 Week's Low
52 Week's High
$0.55
52-Week Price Range
$2.67
$1.03
46.59%
Downside
159.22%
Upside

Cognition Therapeutics share price movements today

Previous Close: $1.05
Open: $1.04
Volume: 825.4K
Market Cap: $99.8M
Day's Low - High: $1.01 - $1.04
52 Week Low - High: $0.55 - $2.67

Cognition Therapeutics Historical Returns

1 Month Return: + 6.48 %
3 Month Return: -22.79 %
1 Year Return: -59.46 %
3 Year Return: -32.69 %
5 Year Return: 0 %

Cognition Therapeutics Stock Fundamentals & Key Indicators

Check Cognition Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$99.8M

EPS (TTM)

-0.192

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.47

Industry PE ratio

-1.63

PEG Ratio

-0.03412040211212476

EBITDA

-16.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-50.17%

Cognition Therapeutics Stock Valuation

Track how Cognition Therapeutics P/E has moved over time to understand its valuation trends.

Cognition Therapeutics in the last 5 years

Overview
Trends

Lowest (-11.99x)

December 31, 2021

Today (-4.22x)

December 31, 2025

Industry (-1.63x)

December 31, 2025

Highest (80.43x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -4.22x

Cognition Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cognition Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cognition Therapeutics	BUY	$99.8M	NA	-5.47	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$141.1B	181.73%	32.21	86.04%	NA
Moderna	BUY	$60.2B	-64.27%	-18.66	-12.57%	NA
Regeneron	BUY	$84.8B	24.12%	20.14	84.86%	0.44%

Stock Returns calculator for Cognition Therapeutics Stock including INR - Dollar returns

The Cognition Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cognition Therapeutics investment value today

Current value as on today

₹42,606

Returns

-₹57,394

(-57.39%)

Returns from Cognition Therapeutics Stock

-₹60,232 (-60.23%)

Dollar Impact

₹2,837 (+2.84%)

Analyst Recommendation on Cognition Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Cognition Therapeutics. Average target price of $3.33

Cognition Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Cognition Therapeutics.

What analysts predicted

69.07%UPSIDE

Target Price

$3.33

Current Price

$1.03

Analyzed by

1 Analysts

Target

$3.33

Cognition Therapeutics target price $3.33, a slight upside of 69.07% compared to current price of $1.03. According to 1 analysts rating.

Indian Investors' Interest in Cognition Therapeutics Stock

Search interest for Cognition Therapeutics Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 6, 2026 to September 5, 2026

Change:17% versus previous 30 day period

Cognition Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-	-	-	-	0	-	0	-
Operating Income	-14	-14	-14	-10	-13	-13	-6	-13	-8	-7
EBITDA	-9	-6	-9	-7	-8	-6	-4	-3	-4	-3
Interest Expense	0	0	0	0	0	0	-	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-9	-7	-9	-7	-8	-6	-4	-3	-4	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-9	-7	-9	-7	-8	-6	-4	-3	-4	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cognition Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	-	0	-	-	-
Operating Income	-17	-17	-28	-43	-50	-53	-47
EBITDA	-3	-5	-10	-21	-25	-33	-23
Interest Expense	1	1	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-4	-7	-11	-21	-25	-33	-23
Income Tax Expense	-	-	-	-22	-	-	-
Net Income	-6	-10	-11	0	-25	-33	-23
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cognition Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-9	-7	-9	-7	-8	-6	-4	-3	-4	-3
Operating Cash Flow	-7	-5	-6	-8	-9	-5	-5	-3	-5	-3
Investing Cash Flow	-	0	-	0	-	-	-	0	-	0
Financing Cash Flow	11	0	0	11	1	0	33	0	0	6
Change in Cash	4	-6	-6	2	-8	-4	28	-2	-5	3

Cognition Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-7	-11	-21	-25	-33	-23
Operating Cash Flow	-3	-3	-3	-18	-16	-28	-24
Investing Cash Flow	0	0	0	0	0	0	0
Financing Cash Flow	2	5	53	5	4	23	36
Change in Cash	0	2	49	-13	-11	-4	11

Mutual Funds that own Cognition Therapeutics Stock

Check out the Mutual Funds with significant holdings in Cognition Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	3.082437%	2931205
Fidelity Concord Street Trust	0.766202%	728611
SCHWAB CAPITAL TRUST	0.089322%	84940
VANGUARD VALLEY FORGE FUNDS	0.040786%	38785
VANGUARD INSTITUTIONAL INDEX FUNDS	0.033437%	31797

See all

Global Institutional Holdings in Cognition Therapeutics

Funds	Holdings
Vanguard	3.54%
iShares	0.29%
Kenneth Tropin	0.16%
Mario Gabelli	0.02%

Insights on Cognition Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CGTX stock has moved up by 2.9%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 513.1% return, outperforming this stock by 572.6%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 32.3% return, outperforming this stock by 65.0%

About Cognition Therapeutics

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer's disease and Mild Cognitive Impairment, as well as geographic atrophy secondary to dry age-related macular degeneration and dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

Organisation	Cognition Therapeutics
Headquarters	2500 Westchester Ave., Purchase, NY, United States, 10577
Industry	Biotechnology
CEO	Ms. Lisa Ricciardi
E-voting on shares	Click here to vote

Key Management of Cognition Therapeutics

Name	Title
Mr. John Brendan Doyle	Chief Financial Officer
Dr. Anthony O. Caggiano M.D., Ph.D.	Chief Medical Officer
Dr. Steven A. Weissman Ph.D.	VP & Head of CMC
Ms. Anita Cornet	Head of Quality
Mr. Bobby Horn	Corporate Controller
Ms. Lisa Ricciardi	CEO, President & Director

FAQs

What is Cognition Therapeutics share price today?

Cognition Therapeutics share price today is $1.03 as on September 5, 2026 at 1:29 am IST at the close of the market. Cognition Therapeutics share today touched a day high of $1.04 and a low of $1.01.

What is the 52 week high and 52 week low for Cognition Therapeutics share?

Cognition Therapeutics share touched a 52 week high of $2.67 on September 5, 2025 and a 52 week low of $0.55 on March 30, 2026. Cognition Therapeutics stock price today i.e. September 5, 2026 at 1:29 am IST is closed at $1.03,which is 61.42% down from its 52 week high and 87.24% up from its 52 week low.

What is Cognition Therapeutics's market capitalisation today?

Cognition Therapeutics market capitalisation is $0.00T as on September 5, 2026 at 1:29 am IST.

How to invest in Cognition Therapeutics Stock (CGTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cognition Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cognition Therapeutics Shares that will get you 1.4563 shares as per Cognition Therapeutics share price of $1.03 per share as on September 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cognition Therapeutics Stock (CGTX) from India?

Indian investors can start investing in Cognition Therapeutics (CGTX) shares with as little as ₹94.485 or $1 (as of September 5, 2026 at 5:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Cognition Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 5, 2026 at 5:41 am IST). Based on Cognition Therapeutics share’s latest price of $1.03 as on September 5, 2026 at 1:29 am IST, you will get 9.7087 shares of Cognition Therapeutics. Learn more about fractional shares .